Brandon S. Imber

2.1k total citations
98 papers, 1.1k citations indexed

About

Brandon S. Imber is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Brandon S. Imber has authored 98 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 39 papers in Oncology and 28 papers in Pathology and Forensic Medicine. Recurrent topics in Brandon S. Imber's work include Lymphoma Diagnosis and Treatment (28 papers), Brain Metastases and Treatment (26 papers) and Glioma Diagnosis and Treatment (21 papers). Brandon S. Imber is often cited by papers focused on Lymphoma Diagnosis and Treatment (28 papers), Brain Metastases and Treatment (26 papers) and Glioma Diagnosis and Treatment (21 papers). Brandon S. Imber collaborates with scholars based in United States, China and United Kingdom. Brandon S. Imber's co-authors include Manish K. Aghi, Edward F. Chang, Srikantan S. Nagarajan, Susanne Honma, Mary Mantle, Danielle Mizuiri, Robert C. Knowlton, Dario J. Englot, Heidi E. Kirsch and Joachim Yahalom and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Brandon S. Imber

82 papers receiving 1.1k citations

Peers

Brandon S. Imber
Fred H. Laningham United States
Dominique Figarella‐Branger France
Mateo Ziu United States
Paolo Galluzzi Italy
Mitsuhiro Hara Japan
R. Hustinx Belgium
Olivier Kerdraon France
Hendrikus G. J. Krouwer United States
Scott D. Wait United States
Maria D’Souza India
Fred H. Laningham United States
Brandon S. Imber
Citations per year, relative to Brandon S. Imber Brandon S. Imber (= 1×) peers Fred H. Laningham

Countries citing papers authored by Brandon S. Imber

Since Specialization
Citations

This map shows the geographic impact of Brandon S. Imber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandon S. Imber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandon S. Imber more than expected).

Fields of papers citing papers by Brandon S. Imber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandon S. Imber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandon S. Imber. The network helps show where Brandon S. Imber may publish in the future.

Co-authorship network of co-authors of Brandon S. Imber

This figure shows the co-authorship network connecting the top 25 collaborators of Brandon S. Imber. A scholar is included among the top collaborators of Brandon S. Imber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandon S. Imber. Brandon S. Imber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Imber, Brandon S., et al.. (2024). The Role of Radiotherapy in Lymphoma Patients Undergoing CAR T Therapy: Past, Present, and Future. Seminars in Radiation Oncology. 35(1). 99–109. 4 indexed citations
2.
Tringale, Kathryn R., Michael Scordo, Joachim Yahalom, et al.. (2024). Evolving consolidation patterns and outcomes for a large cohort of patients with primary CNS lymphoma. Blood Advances. 8(24). 6195–6206. 8 indexed citations
3.
Deschênes‐Simard, Xavier, Martina Pennisi, Miguel‐Angel Perales, et al.. (2024). Severe toxicity, but long-term persistence of CAR T cells after immune checkpoint inhibitors in large B-cell lymphoma. Leukemia & lymphoma. 66(3). 535–540.
4.
Tringale, Kathryn R., Anna Skakodub, Jacklynn V. Egger, et al.. (2024). Prognostic Implications of Small Cell Lung Cancer Transcriptional Subtyping for CNS Metastases. JCO Precision Oncology. 8(8). e2300470–e2300470. 2 indexed citations
5.
Tringale, Kathryn R., Christian Grommes, Anne S. Reiner, et al.. (2024). Consolidation Regimen and Cerebral Atrophy in Patients With Primary Central Nervous System Lymphoma. International Journal of Radiation Oncology*Biology*Physics. 121(5). 1248–1257. 1 indexed citations
6.
Imber, Brandon S., Rupesh Kotecha, Rosemary J. Young, et al.. (2024). Multi-Center Phase I Study of Concurrent Paxalisib and Radiation Therapy in Patients with Solid Tumor Brain Metastases (BM) or Leptomeningeal Metastases (LM) Harboring PI3K Pathway Mutations. International Journal of Radiation Oncology*Biology*Physics. 120(2). S193–S193.
7.
Cederquist, G., Kathryn R. Tringale, Carla Hajj, et al.. (2023). Salvage Radiotherapy as a Bridge for Relapsed Secondary CNS Lymphoma. International Journal of Radiation Oncology*Biology*Physics. 117(2). e459–e459. 1 indexed citations
8.
Imber, Brandon S., Lisa Bodei, John L. Humm, et al.. (2023). A Pilot Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for Oligometastatic Hormone Sensitive Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). e112–e112. 2 indexed citations
9.
Ma, Jennifer, Reith Sarkar, G. Cederquist, et al.. (2023). Radiation in a New Era of Multiple Myeloma Management: Patterns of Utilization, Clinical, Radiologic, and Biochemical Outcomes, and Possible Genomic Correlates of Response. International Journal of Radiation Oncology*Biology*Physics. 117(2). S108–S109.
10.
Skakodub, Anna, Henry Walch, Kathryn R. Tringale, et al.. (2023). Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis. Nature Communications. 14(1). 4980–4980. 28 indexed citations
11.
Freret, Morgan E., Kathryn R. Tringale, Brandon S. Imber, et al.. (2023). Very low-dose radiotherapy for extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue. Leukemia & lymphoma. 64(13). 2195–2201. 2 indexed citations
12.
Aristophanous, Michalis, Brandon S. Imber, C. Gui, et al.. (2023). Failure Mode and Effects Analysis Prior to the Introduction of AI Generated GTVs for Brain Metastases in the Clinical Workflow. International Journal of Radiation Oncology*Biology*Physics. 117(2). S88–S88. 1 indexed citations
13.
Gaëta, Bruno, Henry Walch, Lukáš Kratochvíl, et al.. (2023). The Impact of Co-Alterations on Outcomes after Local Therapy for Patients with KRAS-Mutant Lung Adenocarcinoma Brain Metastases. International Journal of Radiation Oncology*Biology*Physics. 117(2). e101–e102. 2 indexed citations
14.
Cederquist, G., Javin Schefflein, Sean M. Devlin, et al.. (2023). CNS Radiotherapy As Bridging Prior to CAR T-Cell Therapy for Non-Hodgkin B-Cell Lymphoma. Blood. 142(Supplement 1). 4491–4491. 1 indexed citations
15.
Imber, Brandon S., Joachim Yahalom, & M. Lia Palomba. (2023). A PHASE I STUDY OF SPLIT‐COURSE BRIDGING RADIOTHERAPY (SC‐BRT) PRIOR TO COMMERCIAL CD19 CAR T‐CELL THERAPIES FOR PATIENTS WITH RELAPSED OR REFRACTORY B‐CELL LYMPHOMAS. Hematological Oncology. 41(S2). 826–828. 1 indexed citations
16.
Qi, Shu‐Nan, Xin Liu, Ariela Noy, et al.. (2022). Predictors of survival in patients with MALT lymphoma: a retrospective, case-control study. Blood Advances. 7(8). 1496–1506. 7 indexed citations
17.
Lumish, Melissa, Lorenzo Falchi, Brandon S. Imber, et al.. (2021). How we treat mature B-cell neoplasms (indolent B-cell lymphomas). Journal of Hematology & Oncology. 14(1). 5–5. 22 indexed citations
18.
Imber, Brandon S., Andrew Lin, Zhigang Zhang, et al.. (2019). Comparison of Radiographic Approaches to Assess Treatment Response in Pituitary Adenomas: Is RECIST or RANO Good Enough?. Journal of the Endocrine Society. 3(9). 1693–1706. 22 indexed citations
19.
Imber, Brandon S., M. Lia Palomba, Carl J. DeSelm, et al.. (2019). MSKCC Early Experience Using Radiotherapy As a Bridging Strategy for Relapsed Diffuse Large B Cell Lymphoma before CD19 CAR T Therapy. Blood. 134(Supplement_1). 3238–3238. 8 indexed citations
20.
Shepherd, Annemarie F., Jonathan E. Leeman, Aaron T. Wild, et al.. (2017). A Comparison of Trimodality Therapy Versus Definitive Concurrent Chemoradiation in Patients With Stage IIIA Non–small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 99(2). E495–E496. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fred H. Laningham Breakdown of academic impact, for papers by Dominique Figarella‐Branger Breakdown of academic impact, for papers by Mateo Ziu Breakdown of academic impact, for papers by Paolo Galluzzi Breakdown of academic impact, for papers by Mitsuhiro Hara Breakdown of academic impact, for papers by R. Hustinx Breakdown of academic impact, for papers by Olivier Kerdraon Breakdown of academic impact, for papers by Hendrikus G. J. Krouwer Breakdown of academic impact, for papers by Scott D. Wait Breakdown of academic impact, for papers by Maria D’Souza
Rankless by CCL
2026